Martinus Løvik
Professor II Institutt for kreftforskning og molekylær medisin Institutt for samfunnsmedisinmartinus.lovik@ntnu.no
Bakgrunn og aktiviteter
Stilling:
- Professor emeritus, NTNU, Trondheim
- Ekspert for European Food Safety Authority (EFSA), Parma, Italia
Utdanning:
1990 - Bedømt professorkompetent i miljømedisin (København), immunologi (Oslo) og eksperimentell patologi (Uppsala).
- 1987: Spesialist i immunologi og transfusjonsmedisin.
- 1986: Medisinsk doktorgrad (immunologi), UiO
- 1975: Autorisert lege
- 1967 – 1973: Universitetet i Oslo - Cand. med.
- 1964-1967 Militært språkkurs i russisk, russisk mellomfag (UiO)
Arbeidserfaring:
- 2014- : Norges teknisk-naturvitenskapelege universitet (NTNU) - Professor emeritus
- 2000 – 2013: Norges teknisk-naturvitenskapelege universitet (NTNU) - Professor II i medisin (allergi- og infeksjonsimmunologi)
- 1985 – 2013: Folkehelseinstituttet - Spesiallege/overlege/seksjonsleiar/avdelingsdirektør
- 1983 – 1985: Trudeau Institute, NY, USA/NIH/Forskningsrådet - Gjesteforskar
- 1982 – 1983: Avdeling for immunologi, SIFF - Assistentlege
- 1975 - 1982: Norges forskningsråd/Universitetet i Oslo - Forskningsstipendiat, amanuensisvikar
Øvrig faglig bakgrunn:
- 2014 – : Medlem av vitenskapskomiteen for mattrygghets faggruppe for ernæring, dietetiske produkter, ny mat og allergi
- 2003 – : EFSA - Ekspert i panel (NDA, GMO) og arbeidsgrupper, Kritisk litteratur- og dossier-gjennomgang, utarbeiding av saksdokument ('Opinions' og Guidelines)
- 1998 – 2000: Norsk selskap for immunologi, Verv: Formann
- 1988 – : Medlem av ei lang rekkje nasjonale, europeiske, amerikanske og WHO-arbeidsgrupper innanfor immunologi, immuntoksikologi, allergologi og forsøksdyrarbeid
- 1987 – : Prosjektleiar for ei lang rekkje nasjonalt eller EU-finansierte forskningsprosjekt
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2015) Cry1Ab Protein from Bacillus thuringiensis and MON810 cry1Ab-transgenic Maize Exerts No Adjuvant Effect After Airway Exposure. Scandinavian Journal of Immunology. vol. 81 (3).
- (2015) Humoral and cellular immune responses in mice after airway administration of Bacillus thuringiensis Cry1Ab and MON810 cry1Ab-transgenic maize. Food and Agricultural Immunology. vol. 26 (4).
- (2015) Exposure to bisphenol A, but not phthalates, increases spontaneous diabetes type 1 development in NOD mice. Toxicology reports. vol. 2.
- (2015) Early life exposure to bisphenol A investigated in mouse models of airway allergy, food allergy and oral tolerance. Food and Chemical Toxicology. vol. 83.
- (2014) Particles influence allergic responses in mice - role of gender and particle size. Journal of Toxicology and Environmental Health. vol. 77 (5).
- (2014) Pollen from genetically modified Bt maize does not promote allergic responses in mice. Journal of Allergy and Clinical Immunology. vol. 133 (2).
- (2014) Scientific Opinion on the annual post-market environmental monitoring (PMEM) report from Monsanto Europe S.A. on the cultivation of genetically modified maize MON 810 in 2012. EFSA Journal. vol. 12 (6).
- (2014) Scientific Opinion on a notification (reference C/NL/09/01) for the placing on the market of the genetically modified carnation IFD-25958-3 with a modified colour, for import of cut flowers for ornamental use, under Part C of Directive 2001/18/EC from Florigene. EFSA Journal. vol. 12 (12).
- (2014) Scientific Opinion on a notification (reference C/NL/09/02) for the placing on the market of the genetically modified carnation IFD-26407-2 with a modified colour, for import of cut flowers for ornamental use, under Part C of Directive 2001/18/EC from Florigene. EFSA Journal. vol. 12 (12).
- (2014) Scientific Opinion on application (EFSA-GMO-NL-2010-77) for the placing on the market of herbicide-tolerant genetically modified cotton GHB614 × LLCotton25 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience. EFSA Journal. vol. 12 (5).
- (2014) Scientific Opinion on applications (EFSA-GMO-UK-2008-57 and EFSA-GMO-RX-MON15985) for the placing on the market of insect-resistant genetically modified cotton MON 15985 for food and feed uses, import and processing, and for the renewal of authorisation of existing products produced from cotton MON 15985, both under Regulation (EC) No 1829/2003 from Monsanto. EFSA Journal. vol. 12 (7).
- (2014) Statement complementing the EFSA opinion on application EFSA GMO UK 2007 41 (cotton MON 88913 for food and feed uses, import and processing) taking into consideration updated bioinformatic analyses. EFSA Journal. vol. 12 (3).
- (2014) Statement on a request from the European Commission related to the emergency measure notified by Bulgaria on genetically modified maize MON 810 according to Article 34 of Regulation (EC) 1829/2003. EFSA Journal. vol. 12 (12).
- (2014) Food allergens in mattress dust in Norwegian homes - a potentially important source of allergen exposure. Clinical and Experimental Allergy. vol. 44 (1).
- (2014) Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. Journal of Allergy and Clinical Immunology. vol. 133 (2).
- (2014) Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. Toxicological Sciences. vol. 137 (2).
- (2014) Transmaternal Exposure to Bisphenol A, but Not Phthalates, Accelerates Diabetes Type 1 Development in NOD Mice. The Toxicologist. vol. 138 (1).
- (2014) Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: The newgeneris cohort. Environmental Health Perspectives. vol. 122 (2).
- (2014) Modest effects of bisphenol A exposure in mouse models of respiratory allergy and food allergy. Journal of Allergy and Clinical Immunology. vol. 133 (2).
- (2014) In utero exposure to compounds with dioxin-like activity and birth outcomes. Epidemiology. vol. 25 (2).